Health insurer HealthSpring, Inc. (HS), Monday, reported a sharp increase in net income for the fourth quarter that also surpassed analysts' estimate, driven by an over 25% growth in Medicare premium revenue. The Franklin, Tennessee-based company also provided an outlook for the full year 2010, which is better than market view.
Net income for the fourth quarter grew 37% to $38.78 million from $28.31 million last year. Per-share earnings grew 33.3% to $0.68 from $0.51 in the prior-year quarter.
On average, 11 analysts polled by Thomson Reuters expected the company to earn $0.62 per share for the quarter. Analysts' estimates typically exclude special items.
Net revenue for the quarter was $677.61 million compared with $540.84 million in the prior-year quarter, as Medicare premium revenue grew 25.4% to $663.66 million from $529.24 million last year. Eight analysts had a consensus revenue estimate of $661.03 million for the second quarter.
Medicare Advantage premiums, including the prescription drug component of HealthSpring's Medicare Advantage plans, or MA-PD, increased 24.2% to $586.5 million, attributable to increases in both membership and per member per month, or PMPM, premium rates.
Stand-alone PDP premium revenue grew 35.6% to $76.5 million, reflecting a 10.8% increase in membership and an increase in PDP premiums PMPM in the quarter.
For the full year 2009, net income was $133.60 million or $2.41 per share, compared with $118.95 million or $2.12 per share in the last year. Net revenue for the full year totaled $2.67 billion, up 21.8% from $2.19 billion in the previous year. Analysts expected the company to earn $2.35 per share on revenues of $2.65 billion for the full year.
Medicare Advantage premiums were $2.3 billion for the full year, reflecting an increase of 22.5% over the prior year, while Stand-alone PDP premium revenue for the full year grew 22.6% to $325.4 million compared with last year
Herb Fritch, Chief Executive Officer, said "Outperformance in most of our health plans and in our stand-alone prescription drug plan, coupled with continuing SG&A operating leverage, allowed us to close the year on a high note."
Looking ahead, for the full year 2010, the company expects earnings per share in a range of $2.25 to $2.50. Eleven analysts expect the company to earn $2.21 per share for the year.
The company anticipates 2010 full year total revenue to be between $2.85 billion and $2.95 billion, which is better than nine analysts current view of $2.84 billion.
"Moving to 2010, our Medicare Advantage membership has increased. In addition, our stand-alone PDP saw significant auto-assigned membership growth in January. Although our outlook does anticipate a modest increase in our MA MLR, we believe that 2010 will be another good year for HealthSpring," Fritch added.
HS shares closed Friday's regular trading at $17.14 on the NYSE.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.